RNS Number:3764O
Medisys PLC
06 August 2003


Embargoed until 0700                                               6 August 2003

                                  Medisys PLC
                           ("Medisys" or "the Group")

                         Hypoguard Launches Spear Blood
                           Glucose Monitoring System

Medisys announces that Hypoguard, the Group's diagnostics division, has launched
its "Spear" blood glucose monitoring system under the brand name ADVANCE
Micro-drawTM.

ADVANCE Micro-draw combines Hypoguard's proprietary biosensor platform with the
latest capillary fill technology.  The end-fill, capillary action sensor is
designed to wick the sample into the reaction site enabling easier blood sample
application and highly accurate measurements using extremely small blood
samples.  The combination of these features is more convenient and potentially
less painful for the diabetic user.

Advance Micro-draw is comparable to the leading edge products offered in the
retail market today, but will be marketed at a price considerably lower than
those products.  Hypoguard has made ADVANCE Micro-draw available to its US mail
order partners through one of Hypoguard's largest distributors, GEMCO.  It is
anticipated that further mail order distributors will be appointed shortly. The
mail order category represents over 20% of the $2.5 billion US blood glucose
monitoring market.

David Conn, Chief Executive Officer, commented: "Advance Micro-draw offers
leading edge product features and performance and maintains our focus on the
value segment of the market. We see the mail-order channel as the perfect next
step in our strategy to significantly expand our diabetes monitoring business."


                                    - Ends -

Enquiries:

Medisys PLC                                                        020 7563 5200
Michael Barry, Chief Financial Officer

Weber Shandwick Square Mile                                        020 7067 0700
Kevin Smith/Susanne Walker




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

PRLQQLBBXVBXBBV